CRIMINAL DEFENSE BLOG

blog
  • Posted by
  • Apr 21, 2023
  • 2 Comments

THE SCUTTLEBUTT FEATURING ARTICLES ABOUT THE FDA ISSUES MORE WARNING LETTERS TO CBD COMPANIES, RHODE ISLAND TO BEGIN SALES IN DECEMBER AND MORE

In the days of the Armada, a fleet of warships, the scuttlebutt was the rumor or gossip that would spread throughout the ship. Today, Armada Law Corp presents The Scuttlebutt, a daily summery of news articles that people within the cannabis, hemp and plant medicine industries are chatting about along with links to the full articles.

In today’s news:

#psilocybin – “To get ahead of the game, businesses have started acquiring rural properties that could serve as ideal mushroom retreat locations. Existing rural hospitality businesses have also expressed interest in expanding their operations to include psilocybin retreat services.

Many of these would-be operators are now running into a wall of local red tape.

The initiative that legalized magic mushroom businesses allows cities and counties to ban them via ballot initiative. Local governments also retain the power to craft “time, place, and manner” regulations over psilocybin businesses.

This past election, 25 of Oregon’s 36 counties voted to ban psilocybin businesses, including four that voted to legalize psilocybin in 2020. Only two counties that put the questions to voters, Deschutes and Jackson counties, kept these businesses legal.

And this week, those two counties will consider new land use regulations that could severely restrict where newly legal “psilocybin service centers” can set up shop.”

https://reason.com/2022/11/22/oregons-newly-legal-magic-mushroom-industry-could-be-strangled-by-restrictive-zoning-regulations/

#cannabispolitics – “A Senate Democrat has introduced a bill that would require the Small Business Administration to give loans to companies directly or indirectly engaged in the state-sanctioned cannabis industry, according to an announcement from Sen. Jacky Rosen’s office.

Rosen, D-Nev., said her bill, the Fair Access for Cannabis Small Business Act, would remove the obstacles cannabis entrepreneurs face, giving them access to federal support like any other legally operated venture. Rosen is a member of the Senate Committee on Small Business and Entrepreneurship.

“This legislation will level the playing field so that cannabis small businesses — including those owned by people of color, women and veterans — have access to the same federal resources and loans that other legal businesses are entitled to,” Rosen said in a statement.”

https://www.law360.com/articles/1551934/senator-pitches-bill-to-allow-pot-cos-access-to-sba-loans

#cannabisindustry – “Recreational cannabis sales in Rhode Island will commence by Dec. 1 after five medical marijuana dispensaries in the state were cleared to begin selling to general retail customers 21 and over, the governor announced on Tuesday.

The announcement comes almost exactly half a year after Democratic Gov. Daniel J. McKee approved the Rhode Island Cannabis Act in May, a piece of legislation that cleared the way for existing medical cannabis sellers to convert into “hybrid retail” locations.”

https://www.law360.com/articles/1551923/rhode-island-retail-pot-sales-cleared-to-begin-in-december

#cbdproducts – “The U.S. Food and Drug Administration (FDA) has issued its latest batch of warning letters to five companies that the agency claims are illegally selling CBD food and beverage products.

The FDA issued the warning letters to 11-11-11 Brands, Naturally Infused LLC, Newhere Inc dba CBDFX, Infusionz LLC and CBD American Shaman LLC, according to the agency’s Nov. 21 news release.

“These companies are selling CBD-containing products that people may confuse for traditional foods or beverages, which may result in unintentional consumption or overconsumption of CBD,” FDA officials said in the release. “CBD-containing products in forms that are appealing to children, such as gummies, hard candies and cookies, are especially concerning.”

The five warning letters, dated Nov. 16, also outline violations related to the Federal Food, Drug, and Cosmetic (FD&C) Act, according to the release. These violations include the sale of unapproved CBD products that claim to cure, mitigate, treat or prevent diseases, as well as adding CBD to animal foods.”

https://www.cannabisbusinesstimes.com/article/fda-warns-five-companies-for-illegally-selling-cbd-food-beverage-products/